Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Group M: Midazolam intranasal spray: 0.2 mg/kg of intranasal midazolam once 30 minutes before shifting inside the operating room/giving general anaesthesia
Control Intervention1: Group
Sponsors
Alok Belgaumkar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children aged 4 to 10 years 2. ASA Class I & II patients 3. Undergoing elective surgeries under general anaesthesia 4. Willingness of parent/guardian to provide informed consent
Exclusion criteria
Exclusion criteria: 1. Parent refusal for consent 2. Known allergy or contraindication to midazolam or dexmedetomidine 3. Patients with upper respiratory tract infection or nasal pathology 4. Children with cardiovascular, renal, hepatic, or neurological disorders 5. History of delayed development or psychological disorders 6. Children on sedative or antiepileptic medications 7. Emergency surgeries
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| There is no significant difference between intranasal midazolam and intranasal dexmedetomidine in terms of sedation quality, anxiolysis, and perioperative cooperation in paediatric patients.Timepoint: Baseline (before intranasal drug), 15 minutes and 30 minutes after intranasal premedication in preoperative holding area. | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactAlok Belgaumkar
Sri Sidhartha Medical College
Outcome results
None listed